Indivior Pharmaceuticals, Inc. Company Profile
Indivior Pharmaceuticals, Inc. as SEC EDGAR records it: incorporation, addresses, industry, fiscal year end, filer category and former names.
- Incorporated: Value 2005-03-30.
- Current registered country: Value Delaware, United States.
- Country of operation (business address): Value United States.
- Business address: Value 9715 KEY WEST AVENUE, ROCKVILLE, Maryland, 20850, United States.
| Measure | Value |
|---|---|
| Incorporated | 2005-03-30 “Organization and Nature of Operations Supernus Pharmaceuticals, Inc. (the Company) was incorporated in Delaware on March 30, 2005, and commenced operations on December 22, 2005.” 10-K filed 2017-03-16 |
| Current registered country | Delaware, United States SEC EDGAR state of incorporation DE |
| Country of operation (business address) | United States |
| Business address | 9715 KEY WEST AVENUE, ROCKVILLE, Maryland, 20850, United States |
| Mailing address | 9715 KEY WEST AVENUE, ROCKVILLE, Maryland, 20850, United States |
| Industry (SIC) | 2834 Pharmaceutical Preparations |
| Fiscal year end | 12-31 |
| Filer category | Large accelerated filer |
| Listed stock (Section 12(b)) | Common Stock, $0.001 par value per share · SUPN · The Nasdaq Global Market 10-Q filed 2026-08-03 cover |
| Shell company | No 10-Q filed 2026-08-03 cover |
| Smaller reporting company | No 10-Q filed 2026-08-03 cover |
| Emerging growth company | No 10-Q filed 2026-08-03 cover |
| Current in its reporting | Yes 10-Q filed 2026-08-03 cover |
| Well-known seasoned issuer | Yes 10-K filed 2026-03-02 cover |
| Voluntary filer | No 10-K filed 2026-03-02 cover |
| Former names | SUPERNUS PHARMACEUTICALS INC (2006-03-06 to 2019-06-12) |
| First EDGAR filing | 2006-03-06 (REGDEX/A) |
| SEC CIK | 1356576 |
| EIN | 000000000 |
| Phone | 301-838-2500 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |